Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 226-250 of 861 matching filings.

Per page
25
Current page
10
3

FORM 3 SUBMISSION

Filing date
24 Feb 2021
Reporting date
24 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
24 Feb 2021
Reporting date
24 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
24 Feb 2021
Reporting date
24 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
24 Feb 2021
Reporting date
24 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K 2021 STOCKHOLDERS MEETING

Filing date
23 Feb 2021
Reporting date
22 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-51531

425

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SCHEDULE 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

AMENDMENT NO. 7 TO THE SCHEDULE 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K SHAREHOLDER LITIGATION

Filing date
12 Feb 2021
Reporting date
12 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-51531

8-K SHAREHOLDER LITIGATION

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-51531

425

Filing date
11 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-251567

EFFECT filing

Filing date
14 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-251567

424B3

Filing date
14 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
07 Jan 2021
Reporting date
01 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SABBY 13G-A 1.07.21

Filing date
07 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 000-51531

425

Filing date
07 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81034

SC 13G filing

Filing date
04 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
29 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
22 Dec 2020
Reporting date
16 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .